Biotech Beach Bum

Closer to home, Amylin defends itself from takeover moves by Icahn and Eastbourne Capital Management, who urge sale to a big pharma buyer.
 
http://www.xconomy.com/san-diego/2009/05/11/amylin-urges-shareholders-to-vote-blue/